Ting Feng
Directeur/Membre du Conseil chez Beijing Jiakesi New Drug Development Co. Ltd.
Profil
Ting Feng, Ph.D., is a Vice President with Lilly Asia Ventures (LAV).
Prior to joining LAV, Ting was a Senior Investment Manager at SAIF Partners, focusing on healthcare investment in China.
Prior to SAIF, Ting worked as a Senior Consultant at IMS Consulting Group and postdoctoral fellow at Harvard Medical School.
Ting holds a Ph.D.
in Immunology from University of Alabama at Birmingham and B.S.
in Biotechnology from Wuhan University.
Postes actifs de Ting Feng
| Sociétés | Poste | Début |
|---|---|---|
Beijing Jiakesi New Drug Development Co. Ltd.
 Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Directeur/Membre du Conseil | 01/02/2020 |
| Jacobio Hk Pharmaceuticals Co. Ltd. | Directeur/Membre du Conseil | 01/02/2020 |
| Lav Advanced Management Shanghai Co. Ltd. | Corporate Officer/Principal | 01/12/2018 |
Synnovation Therapeutics, Inc.
 Synnovation Therapeutics, Inc. BiotechnologyHealth Technology Synnovation Therapeutics, Inc. develops novel small molecule targeted therapies for cancer patients. The company is located in the US. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ting Feng
| Sociétés | Poste | Fin |
|---|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Directeur/Membre du Conseil | 22/03/2022 |
LAV Management Co., Ltd.
 LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Private Equity Investor | 01/01/2022 |
SAIF Partners Ltd. (China)
 SAIF Partners Ltd. (China) Investment ManagersFinance SAIF Partners China is the China-based private equity subsidiary of SAIF Partners Hong Kong, a leading private equity firm that provides growth capital to companies in Asia. Founded in 2001, SAIF Partners China has offices in Beijing, Shanghai and Tianjin. In addition to the Chinese offices, SAIF Partners has their headquarters in Hong Kong, with dedicated local offices in India (Hyderabad, New Delhi), and South Korea (Seoul). | Directeur en chef des Investissements | 01/11/2018 |
Formation de Ting Feng
| Wuhan University | Undergraduate Degree |
| The University of Alabama at Birmingham | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| JACOBIO PHARMACEUTICALS GROUP CO., LTD. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Beijing Jiakesi New Drug Development Co. Ltd.
Beijing Jiakesi New Drug Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Beijing Jiakesi New Drug Development Co. Ltd. develops and sells drugs. The company was founded by Yinxiang Wang on July 17, 2015 and is headquartered in Beijing, China. | Health Technology |
| Jacobio Hk Pharmaceuticals Co. Ltd. | |
SAIF Partners Ltd. (China)
SAIF Partners Ltd. (China) Investment ManagersFinance SAIF Partners China is the China-based private equity subsidiary of SAIF Partners Hong Kong, a leading private equity firm that provides growth capital to companies in Asia. Founded in 2001, SAIF Partners China has offices in Beijing, Shanghai and Tianjin. In addition to the Chinese offices, SAIF Partners has their headquarters in Hong Kong, with dedicated local offices in India (Hyderabad, New Delhi), and South Korea (Seoul). | Finance |
| Lav Advanced Management Shanghai Co. Ltd. | |
Synnovation Therapeutics, Inc.
Synnovation Therapeutics, Inc. BiotechnologyHealth Technology Synnovation Therapeutics, Inc. develops novel small molecule targeted therapies for cancer patients. The company is located in the US. | Health Technology |
LAV Management Co., Ltd.
LAV Management Co., Ltd. Investment ManagersFinance LAV Management Co., Ltd. (LAV) is a venture capital subsidiary of Eli Lilly & Co. founded in 2008. The firm is headquartered in Shanghai, China with branches located in Central, Hong Kong and California, United States. | Finance |
